Marco Pagni - Walgreens Boots President
WBA Stock | USD 21.69 0.67 3.19% |
President
Mr. Marco Patrick Anthony Pagni serves as Executive Vice President, Global Chief Administrative Officer and General Counsel of the Company. He served as Executive Vice President, Global Chief Legal and Administrative Officer from February 2015 to February 2016. Previously, he served as Executive Director and Group Legal Counsel and Chief Administrative Officer of Alliance Boots from 2007 to 2014 and General Counsel and Company Secretary for Alliance Boots from 2006 to 2007, having joined Alliance UniChem, a predecessor company, in the same position in 2003. Prior to this, Mr. Pagni served at McDonalds Corporation for 10 years in a number of senior management positions across the world, including in the U.S. and UK, such as Vice President of International Development, and Vice President, General Counsel, International. Mr. Pagni serves as a director of Sprint Acquisitions Holdings Limited and, until February 2015, served as a director of Alliance Boots. since 2016.
Age | 55 |
Tenure | 8 years |
Address | 108 Wilmot Road, Deerfield, IL, United States, 60015 |
Phone | 847 315 3700 |
Web | https://www.walgreensbootsalliance.com |
Walgreens Boots Management Efficiency
The company has Return on Asset of 0.0132 % which means that on every $100 spent on assets, it made $0.0132 of profit. This is way below average. Walgreens Boots' management efficiency ratios could be used to measure how well Walgreens Boots manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Capital Employed is expected to grow to -0.1. The current year's Return On Assets is expected to grow to -0.03. At present, Walgreens Boots' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 98 B, whereas Total Current Assets are forecasted to decline to about 9.2 B.Similar Executives
Showing other executives | PRESIDENT Age | ||
Kathleen Reardon | Dollar General | 52 | |
Jeffery Owen | Dollar General | 54 | |
Kirk Saville | BJs Wholesale Club | 55 | |
Michael Kindy | Dollar General | 53 | |
Monica Schwartz | BJs Wholesale Club | 49 | |
Prashant RPh | Trxade Group | 50 | |
Rafeh Masood | BJs Wholesale Club | 41 | |
Jariel Morales | Trxade Group | N/A | |
Scott Kessler | BJs Wholesale Club | 57 | |
Caroline Glynn | BJs Wholesale Club | 56 | |
Jason Reiser | Dollar General | 50 | |
Brian Poulliot | BJs Wholesale Club | 49 | |
Graham Luce | BJs Wholesale Club | 54 | |
Jeff Owen | Dollar General | N/A | |
Rhonda Taylor | Dollar General | 56 | |
William Werner | BJs Wholesale Club | 46 | |
Laura Felice | BJs Wholesale Club | 38 | |
John Garratt | Dollar General | 55 | |
Carman Wenkoff | Dollar General | 56 | |
James Thorpe | Dollar General | 56 | |
Jeff Desroches | BJs Wholesale Club | 47 |
Management Performance
Return On Equity | 4.0E-4 | ||||
Return On Asset | 0.0132 |
Walgreens Boots Alliance Leadership Team
Elected by the shareholders, the Walgreens Boots' board of directors comprises two types of representatives: Walgreens Boots inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Walgreens. The board's role is to monitor Walgreens Boots' management team and ensure that shareholders' interests are well served. Walgreens Boots' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Walgreens Boots' outside directors are responsible for providing unbiased perspectives on the board's policies.
Alexander Gourlay, Executive VP and President of Walgreens Co | ||
James Skinner, Executive Chairman | ||
David Brailer, Independent Director | ||
Joseph Amsbary, Senior Secretary | ||
Leonard Schaeffer, Independent Director | ||
Nancy Schlichting, Independent Director | ||
Dominic Murphy, Director | ||
Jan Reed, Senior Vice President General Counsel, Corporatye Secretary | ||
James Kehoe, Global CFO, Executive Vice President - Global | ||
Anthony Roberts, Senior Vice President Global CIO | ||
Holly May, Ex Officer | ||
Beth Leonard, Senior Officer | ||
Marco Pagni, Executive Vice President Global Chief Legal and Administrative Officer | ||
Timothy Wentworth, CEO Director | ||
John Lederer, Director | ||
Ken Murphy, Executive Vice President of Walgreens Boots Alliance and Presidentident of Global Brands | ||
Stefano Pessina, Executive Vice Chairman and CEO | ||
Simon Roberts, Executive Vice President of Walgreens Boots Alliance and President of Boots | ||
Matthew DAmbrosio, Senior Officer | ||
Rick Gates, Senior Co | ||
Neal Sample, Executive Officer | ||
Gerald Gradwell, IR Contact Officer | ||
Rosalind Brewer, CEO Director | ||
Tracey Brown, President VP | ||
Heather Dixon, Senior Vice President Chief Accounting Officer, Global Controller | ||
Kimberly Scardino, Senior Vice President Chief Accounting Officer, Global Controller | ||
Kathleen WilsonThompson, Executive Vice President Global Chief Human Resources Officer | ||
Hsiao Wang, VP Officer | ||
Jeffrey Berkowitz, Executive Vice President of Walgreens Boots Alliance and Presidentident of Pharma and Global Market Access | ||
Ornella Barra, Executive Vice President of Walgreens Boots Alliance and Presidentident and Chief Executive of Global Wholesale and International Retail | ||
Barry Rosenstein, Independent Director | ||
Mia Scholz, Sr Operations | ||
John Driscoll, Executive Healthcare | ||
Jose Almeida, Director | ||
Tiffany Kanaga, Vice Relations | ||
Janice Babiak, Independent Director | ||
Liyue Wu, Head Asia | ||
Danielle Gray, Ex Officer | ||
Manmohan Mahajan, Executive CFO | ||
Todd Heckman, Interim VP | ||
William Foote, Lead Independent Director | ||
Ginger Graham, Independent Director | ||
Aaron Radelet, Global VP | ||
Natasha Polster, Compliance Quality | ||
Aidan Clare, Senior Treasurer | ||
George Fairweather, Global CFO and Executive VP | ||
Elizabeth Burger, Executive Officer |
Walgreens Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Walgreens Boots a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 4.0E-4 | ||||
Return On Asset | 0.0132 | ||||
Profit Margin | 0 % | ||||
Operating Margin | (0.0008) % | ||||
Current Valuation | 51.08 B | ||||
Shares Outstanding | 862.38 M | ||||
Shares Owned By Insiders | 17.30 % | ||||
Shares Owned By Institutions | 62.12 % | ||||
Number Of Shares Shorted | 31.16 M | ||||
Price To Earning | 8.10 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.CLSK | CleanSpark | |
V | Visa Class A | |
CDLX | Cardlytics |
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Walgreens Boots Alliance. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Walgreens Boots Alliance information on this page should be used as a complementary analysis to other Walgreens Boots' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Complementary Tools for Walgreens Stock analysis
When running Walgreens Boots' price analysis, check to measure Walgreens Boots' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Walgreens Boots is operating at the current time. Most of Walgreens Boots' value examination focuses on studying past and present price action to predict the probability of Walgreens Boots' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Walgreens Boots' price. Additionally, you may evaluate how the addition of Walgreens Boots to your portfolios can decrease your overall portfolio volatility.
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Content Syndication Quickly integrate customizable finance content to your own investment portal |
Is Walgreens Boots' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Walgreens Boots. If investors know Walgreens will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Walgreens Boots listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.59) | Dividend Share 1.92 | Earnings Share 0.66 | Revenue Per Share 165.003 | Quarterly Revenue Growth 0.1 |
The market value of Walgreens Boots Alliance is measured differently than its book value, which is the value of Walgreens that is recorded on the company's balance sheet. Investors also form their own opinion of Walgreens Boots' value that differs from its market value or its book value, called intrinsic value, which is Walgreens Boots' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Walgreens Boots' market value can be influenced by many factors that don't directly affect Walgreens Boots' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Walgreens Boots' value and its price as these two are different measures arrived at by different means. Investors typically determine if Walgreens Boots is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Walgreens Boots' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.